Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Plasmacytoid Urothelial Bladder Cancer: A Case Report and Review of the Literature.

Gunaratne DA, Krieger LE, Maclean F, Vaux KJ, Chalasani V.

Clin Genitourin Cancer. 2016 Feb;14(1):e103-5. doi: 10.1016/j.clgc.2015.08.009. Epub 2015 Sep 3. Review. No abstract available.

PMID:
26431887
2.

Health-related quality of life using intensity-modulated radiation therapy for post-prostatectomy radiotherapy.

van Gysen KL, Kneebone AB, Guo L, Vaux KJ, Lazzaro EM, Eade TN.

J Med Imaging Radiat Oncol. 2013 Feb;57(1):89-96. doi: 10.1111/j.1754-9485.2012.02464.x. Epub 2012 Oct 17.

PMID:
23374560
3.

Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa.

Mansfield KJ, Chandran JJ, Vaux KJ, Millard RJ, Christopoulos A, Mitchelson FJ, Burcher E.

J Pharmacol Exp Ther. 2009 Mar;328(3):893-9. doi: 10.1124/jpet.108.145508. Epub 2008 Nov 24.

PMID:
19029429
4.
5.

Age-related changes of P2X(1) receptor mRNA in the bladder detrusor from men with and without bladder outlet obstruction.

Chua WC, Liu L, Mansfield KJ, Vaux KJ, Moore KH, Millard RJ, Burcher E.

Exp Gerontol. 2007 Jul;42(7):686-92. Epub 2007 Feb 20.

PMID:
17399929
6.

The molecular basis of urgency: regional difference of vanilloid receptor expression in the human urinary bladder.

Liu L, Mansfield KJ, Kristiana I, Vaux KJ, Millard RJ, Burcher E.

Neurourol Urodyn. 2007;26(3):433-8; discussion 439; discussion 451-3.

PMID:
17016800

Supplemental Content

Support Center